McGuire Investment Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
FTUS
OAM
IWM
IA
SWP
OCM
McGuire Investment Group's GNOM Position: Q2 2025 in Review
McGuire Investment Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 3,546 shares — an estimated $113K sold.
McGuire Investment Group first reported a position in GNOM in Q1 2021 and held it in 17 quarters. The position peaked at $8.55M in Q4 2021. 51 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.
- McGuire Investment Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- McGuire Investment Group sold 3,546 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $113K.
- McGuire Investment Group first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 17 quarters.
- McGuire Investment Group's Global X Genomics & Biotechnology ETF position peaked at $8.55M in Q4 2021.
- 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.
Based on McGuire Investment Group's 13F filing for Q2 2025, filed 18 Jul 2025.